Trials / Completed
CompletedNCT05551364
Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy
Usabilidad y Efectividad Del Exoesqueleto ATLAS2030 en Variables físicas, Emocionales y Funcionales en niños Con parálisis Cerebral
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- MarsiBionics · Industry
- Sex
- All
- Age
- 3 Years – 14 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this study is to assess the usability and efficacy of receiving therapy with the peaditric exoskeleton ATLAS 2030in children with gait impairment due to a cerebral palsy condition. It will be valued the impact of rehabilitation with the exoskeleton at the physical level on parameters such as joint range, spasticity, as well as the impact in quality of life. It is also assessed the impact at the level of functionality of the participants, through the administration of different functional assessment scales.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ATLAS 2030 exoskeleton | Individualized Rehabilitation Treatment with the ATLAS 2030 Exoskeleton consists of the following phases: 1. Telephone contact phase (1 session) 2. Inclusion Phase (1 session) 3. Signing of informed consent (1 session) 4. Initial Evaluation Phase (1 session) 5. Treatment Phase (1st part) (7 sessions) 6. Monthly Evaluation Phase (1 session) 7. Treatment Phase (2nd part) (7 sessions) 8. Monthly Evaluation Phase (1 session) 9. Treatment Phase (3rd part) (7 sessions) 10. Final Evaluation Phase and results (2 sessions) |
Timeline
- Start date
- 2022-09-05
- Primary completion
- 2023-06-02
- Completion
- 2023-08-30
- First posted
- 2022-09-22
- Last updated
- 2024-09-27
Locations
6 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT05551364. Inclusion in this directory is not an endorsement.